Stock listing
A2PF3G Stock Price, News, Filings & Events — Cormedix Inc.
Selected listing: A2PF3G · LSX · EUR · DE
This page tracks Cormedix Inc.'s A2PF3G:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PF3G:LSX. A2PF3G:LSX is the stock-level entry point for investors researching Cormedix Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cormedix Inc. (ticker: CRMD) is a public company operating in the American market, with a market capitalization of approximately $617.4 million. The company focuses on developing and commercializing innovative products to improve patient outcomes in the healthcare sector. Cormedix is committed to addressing unmet medical needs through its research and development efforts.
- Ticker
- A2PF3G:LSX
- Asset type
- Stock
- Market cap
- $646.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Cormedix Inc. A2PF3G:LSX stock context
This page tracks Cormedix Inc.'s A2PF3G:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PF3G:LSX. A2PF3G:LSX is the stock-level entry point for investors researching Cormedix Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cormedix Inc. (ticker: CRMD) is a public company operating in the American market, with a market capitalization of approximately $617.4 million. The company focuses on developing and commercializing innovative products to improve patient outcomes in the healthcare sector. Cormedix is committed to addressing unmet medical needs through its research and development efforts.
Latest news from Cormedix Inc.
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
July 29, 2026
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy B...
July 14, 2026
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
June 8, 2026
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
May 15, 2026
Cormedix Inc. earnings calls
CorMedix Inc. (CRMD) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
CorMedix Inc. (CRMD) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
CorMedix Inc. (CRMD) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
CorMedix Inc. (CRMD) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
CorMedix Inc. (CRMD) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
CorMedix Inc. (CRMD) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Cormedix Inc.
Cormedix Inc. investor report
Review AI stock analysis and investor report context for A2PF3G:LSX.
Cormedix Inc. company profile
View the public company page for Cormedix Inc. on 6ix.
Cormedix Inc. news
Read company news and market updates connected to Cormedix Inc..
Cormedix Inc. investor events
Find investor webinars, events, and replay context for Cormedix Inc..
Alternate listings
CRMD:NASDAQ
US · USD
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:GETTEX
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:TRADEGATE
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:SWB
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
CRMD:BOATS
US · USD
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
A2PF3G:LS
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:FWB
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:MUN
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:DUS
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.
19KA:HAM
DE · EUR
Alternate listing for Cormedix Inc.; the primary context on this page is A2PF3G:LSX.